Compare STTK & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | CARE |
|---|---|---|
| Founded | 2016 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.1M | 507.1M |
| IPO Year | 2020 | 2020 |
| Metric | STTK | CARE |
|---|---|---|
| Price | $7.03 | $25.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $10.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 424.3K | 352.2K |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | ★ 53.02 | 30.19 |
| EPS | N/A | ★ 1.38 |
| Revenue | $1,000,000.00 | ★ $20,315,000.00 |
| Revenue This Year | N/A | $12.50 |
| Revenue Next Year | N/A | $11.82 |
| P/E Ratio | ★ N/A | $18.50 |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.71 | $15.37 |
| 52 Week High | $8.33 | $25.65 |
| Indicator | STTK | CARE |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 78.47 |
| Support Level | $5.75 | $19.34 |
| Resistance Level | $7.68 | N/A |
| Average True Range (ATR) | 0.52 | 0.61 |
| MACD | -0.13 | 0.05 |
| Stochastic Oscillator | 17.27 | 91.22 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.